Core Points - The stock of Wanjian Medical (300888) closed at 43.03 yuan on November 13, 2025, marking a 0.66% increase from the previous trading day, with a total market capitalization of 25.058 billion yuan [1] - The company announced a board meeting on November 12, 2025, where it was decided to grant 500,000 reserved restricted stocks to 13 incentive targets at a grant price of 14.69 yuan per share [1] - The vesting period for the restricted stocks is divided into two phases, with 50% vesting after 18 months and the remaining 50% after 30 months, and the performance assessment period is set for 2026 to 2027 [1] Company Information - The stock opened at 42.8 yuan, reached a high of 43.12 yuan, and a low of 42.37 yuan on the same day, with a trading volume of 2.92 billion yuan and a turnover rate of 1.17% [1] - The performance assessment indicators for the incentive plan include revenue growth rates at the company level, as well as for the medical and consumer goods business segments [1] - The incentive targets do not include directors, senior management, or shareholders holding more than 5% of the shares [1]
稳健医疗(300888)披露向2024年限制性股票激励计划激励对象授予预留限制性股票,11月13日股价上涨0.66%